ArticleFrontiers in oncology2022
Prediction of Transcription Factor Binding Sites Using a Combined Deep Learning Approach.
Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- A Deep Learning Framework with Multi-perspective Feature Fusion for Transcription Factor Binding Site Prediction.Interdisciplinary sciences, computational life sciences · 2026Article
- caRBP-Pred: Leveraging Protein Language Models for the Prediction of Chromatin-Associated RNA-Binding Proteins.Computational and structural biotechnology journal · 2026Article
- Review
- Identifying transcription factors with cell-type specific DNA binding signatures.BMC genomics · 2024Article
- Compensatory Modulation of Seed Storage Protein Synthesis and Alteration of Starch Accumulation by Selective Editing of 13 kDa Prolamin Genes by CRISPR-Cas9 in Rice.International journal of molecular sciences · 2024Article
- Predicting Transcription Factor Binding Sites with Deep Learning.International journal of molecular sciences · 2024Article
- Transformer Architecture and Attention Mechanisms in Genome Data Analysis: A Comprehensive Review.Biology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the process of regulating gene expression and evolution, such as DNA replication and mRNA transcription, the binding of transcription factors (TFs) to TF binding sites (TFBS) plays a vital role. Precisely modeling the specificity of genes and searching for TFBS are helpful to explore the mechanism of cell expression. In recent years, computational and deep learning methods searching for TFBS have become an active field of research. However, existing methods generally cannot meet high performance and interpretability simultaneously. Here, we develop an accurate and interpretable attention-based hybrid approach, DeepARC, that combines a convolutional neural network (CNN) and recurrent neural network (RNN) to predict TFBS. DeepARC employs a positional embedding method to extract the hidden embedding from DNA sequences, including the positional information from OneHot encoding and the distributed embedding from DNA2Vec. DeepARC feeds the positional embedding of the DNA sequence into a CNN-BiLSTM-Attention-based framework to complete the task of finding the motif. Taking advantage of the attention mechanism, DeepARC can gain greater access to valuable information about the motif and bring interpretability to the work of searching for motifs through the attention weight graph. Moreover, DeepARC achieves promising performances with an average area under the receiver operating characteristic curve (AUC) score of 0.908 on five cell lines (A549, GM12878, Hep-G2, H1-hESC, and Hela) in the benchmark dataset. We also compare the positional embedding with OneHot and DNA2Vec and gain a competitive advantage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.